The Relative Risk of Incident Coronary Heart Disease Associated With Recently Stopping the Use of β-Blockers
- 23 March 1990
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 263 (12), 1653-1657
- https://doi.org/10.1001/jama.1990.03440120075040
Abstract
Research from JAMA — The Relative Risk of Incident Coronary Heart Disease Associated With Recently Stopping the Use of β-BlockersKeywords
This publication has 13 references indexed in Scilit:
- β-Blockers and Primary Prevention of Coronary Heart Disease in Patients With High Blood PressurePublished by American Medical Association (AMA) ,1989
- Beta-adrenergic blocker withdrawal syndromes in hypertension and other cardiovascular diseasesAmerican Heart Journal, 1988
- Prognosis after withdrawal of chronic postinfarction metoprolol treatment: a 2–7 year follow-upEuropean Heart Journal, 1988
- Beta-adrenergic blocker withdrawalThe American Journal of Cardiology, 1987
- The role of endogenous noradrenaline in the beta-blocker withdrawal phenomenon — studies with culture heart cellsKlinische Wochenschrift, 1987
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Withdrawal of beta-blocking drugsAmerican Heart Journal, 1982
- Lack of beta-adrenoreceptor hypersensitivity after abrupt withdrawal of long-term therapy with oxprenolol.Circulation, 1981
- An early intervention secondary prevention study with oxprenolol following myocardial infarctionEuropean Heart Journal, 1981
- A pitfall in sampling medical visits.American Journal of Public Health, 1977